Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. The company's primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. Rasna Therapeutics' clinical program is based on three druggable intervention points with a potential to improve safety and efficacy of current AML combination therapies.
|HQ||New York, US||Map|
|Employees (est.) (Feb 2019)||5||(-50%)|
|Revenue (FY, 2017)||$0|
Net income (Q2, 2019)
EBIT (Q2, 2019)
|USD||Q2, 2014||Q3, 2014||Q1, 2015||Q1, 2016||Q2, 2016||Q3, 2016||Q2, 2017||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019|
General and administrative expense
Operating expense total
|USD||Q2, 2014||Q3, 2014||Q1, 2015||Q2, 2016||Q3, 2016||Q2, 2017||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019|
Depreciation and Amortization
Cash From Operating Activities
Rasna Therapeutics has 14 Twitter Followers. The number of followers has increased 15.1% quarter over quarter
When was Rasna Therapeutics founded?
Rasna Therapeutics was founded in 2013.
How many employees does Rasna Therapeutics have?
Rasna Therapeutics has 5 employees.
Who are Rasna Therapeutics competitors?
Competitors of Rasna Therapeutics include Dicerna Pharmaceuticals, LAM Therapeutics and Urogen Pharma.
Where is Rasna Therapeutics headquarters?
Rasna Therapeutics headquarters is located at 420 Lexington Ave #2525, New York.
Where are Rasna Therapeutics offices?
Rasna Therapeutics has offices in New York and Greater London.
How many offices does Rasna Therapeutics have?
Rasna Therapeutics has 2 offices.